The primary goals of type 2 diabetes management extend beyond glycemic control to include prevention of long-term complications, reduction in premature mortality, and improvement in overall quality of life. Traditionally, guidelines have recommended a stepwise approach beginning with lifestyle modification and metformin, followed by treatment intensification when HbA1c exceeds target thresholds. However, in real-world practice, delayed intensification is common, leading to prolonged periods of suboptimal glycemic control, a phenomenon often referred to as clinical inertia.
When coupled with delayed diagnosis, sustained hyperglycemia significantly worsens long-term prognosis. Emerging evidence suggests that early combination therapy using agents with complementary mechanisms may achieve more durable glycemic control compared to metformin monotherapy. Data from the VERIFY study further…
